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Abstract
Background:  Certain murine leukemia viruses (MLVs) are capable of inducing progressive
spongiform motor neuron disease in susceptible mice upon infection of the central nervous system
(CNS). The major CNS parenchymal target of these neurovirulent retroviruses (NVs) are the
microglia, whose infection is largely coincident with neuropathological changes. Despite this close
association, the role of microglial infection in disease induction is still unknown. In this paper, we
investigate the interaction of the highly virulent MLV, FrCasE, with microglia ex vivo to evaluate
whether infection induces specific changes that could account for neurodegeneration. Specifically,
we compared microglia infected with FrCasE, a related non-neurovirulent virus (NN) F43/Fr57E,
or mock-infected, both at a basic virological level, and at the level of cellular gene expression using
quantitative real time RT-PCR (qRT-PCR) and Afffymetrix 430A mouse gene chips.
Results: Basic virological comparison of NN, NV, and mock-infected microglia in culture did not
reveal differences in virus expression that provided insight into neuropathogenesis. Therefore,
microglial analysis was extended to ER stress gene induction based on previous experiments
demonstrating ER stress induction in NV-infected mouse brains and cultured fibroblasts. Analysis
of message levels for the ER stress genes BiP (grp78), CHOP (Gadd153), calreticulin, and grp58 in
cultured microglia, and BiP and CHOP in microglia enriched fractions from infected mouse brains,
indicated that FrCasE infection did not induce these ER stress genes either in vitro or in vivo. To
broadly identify physiological changes resulting from NV infection of microglia in vitro, we
undertook a gene array screen of more than 14,000 well-characterized murine genes and
expressed sequence tags (ESTs). This analysis revealed only a small set of gene expression changes
between infected and uninfected cells (<18). Remarkably, gene array comparison of NN- and NV-
infected microglia revealed only 3 apparent gene expression differences. Validation experiments for
these genes by Taqman real-time RT-PCR indicated that only single Ig IL-1 receptor related protein
(SIGIRR) transcript was consistently altered in culture; however, SIGIRR changes were not
observed in enriched microglial fractions from infected brains.
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Conclusion:  The results from this study indicate that infection of microglia by the highly
neurovirulent virus, FrCasE, does not induce overt physiological changes in this cell type when
assessed ex vivo. In particular, NV does not induce microglial ER stress and thus, FrCasE-associated
CNS ER stress likely results from NV interactions with another cell type or from
neurodegeneration directly. The lack of NV-induced microglial gene expression changes suggests
that FrCasE either affects properties unique to microglia in situ, alters the expression of microglial
genes not represented in this survey, or affects microglial cellular processes at a post-
transcriptional level. Alternatively, NV-infected microglia may simply serve as an unaffected conduit
for persistent dissemination of virus to other neural cells where they produce acute
neuropathogenic effects.
Background
Various murine leukemia viruses (MLVs) are capable of
inducing progressive motor neuron degeneration after
peripheral inoculation into susceptible strains of neonatal
mice (Reviewed in [1-5]). The prototypic virus of this class
is an ecotropic virus referred to as CasBrE, which was orig-
inally isolated from wild mice by Gardner and coworkers
[6]. Clinically, CasBrE and related ecotropic NVs induce
tremulous paralysis with associated wasting that ulti-
mately progresses to death. The primary pathological fea-
ture associated with central nervous system (CNS)
infection is vacuolation, which is largely confined to
motor areas of the brain and spinal cord. For CasBrE and
related viruses, vacuolation appears initially in dendritic
processes and progresses to include neuron and glial cell
bodies [7]. Importantly, CasBrE does not appear to infect
the motor neurons that degenerate; and the macroglia
(astrocytes and oligodendroglia) appear to be only mini-
mally infected [7-10]. Instead, the primary MLV targets in
the CNS parenchyma are the microglia, whose infection
largely colocalizes with neuropathology [7,8,11,12]. The
CNS vascular endothelia are also widely infected by Cas-
BrE derived viruses, which appears to be an important
means for virus entry into the CNS; however, this infec-
tion is not associated with alterations in the blood-brain
barrier [13,14]. Importantly, CNS transplantation analy-
sis using infected microglia and neural stem cells (NSCs)
demonstrated that endothelial cell infection could be
largely bypassed and still induce neuropathology [15-17].
More to the point however, is that the transplantation
experiments suggested that microglial infection alone
may be sufficient for inducing vacuolar neurodegenera-
tion by CasBrE-derived neurovirulent viruses.
The primary MLV sequences harbouring neurovirulence
determinants have been mapped to within the env gene
[18-21], however, the mechanism by which env mediates
disease is not known. In this regard, it has been observed
that NV Env proteins do not appear to specify unique cell
tropism, as similar CNS cell type infection, including
microglial infection, has been observed between closely
related NNs and NVs [12,22]. Moreover, NV Env proteins
do not appear to be acutely neurotoxic when expressed in
the brains of susceptible mice. For example, in susceptible
mice transplanted with NSCs expressing CasBrE Env, no
neuropathological changes were observed within the 4
week assay period [17]. Similarly, transgenic mice engi-
neered to constitutively express NV envs or whole NV
show only very limited neuropathological changes after
protracted time periods [23,24]. Furthermore, experi-
ments in which chimeric brains were generated using
NSCs expressing either replication restricted NVs (limited
to binding, entry and reverse transcription in host target
cells); or defective virus encoding the CasBrE env gene,
acute neuropathological changes were not observed
[16,17]. Together these results suggested that the induc-
tion of neuropathology requires viral entry, reverse tran-
scription, integration, and the expression of viral proteins
in late virus replication events.
In order to understand how NV infection of microglia
might be involved in the induction of neurodegeneration,
neuroinflammatory mechanisms have received a signifi-
cant amount of attention based on the consistent appear-
ance of gliosis in most models of MLV-induced
neuropathogenesis. However, in vivo studies on highly
acute disease models in rats and mice suggest that the neu-
roinflammatory changes observed are simply secondary
responses to neuropathology, rather than proximal dis-
ease causes [7,25-27]. This idea is supported by a more
recent study showing that CasBrE-induced neurodegener-
ation was not abrogated in mice deficient in critical neu-
roinflammatory mediators including Interleukin-6, Fas,
tumor necrosis factor-receptor 1, and inducible nitric
oxide synthetase [28]. Furthermore, recent gene array
analysis on the brainstems of preclinical and clinical
FrCasE-infected mice failed to identify early proinflamma-
tory gene expression changes [29]. To the contrary, certain
types of neuroinflammation may actually prevent neu-
ropathogenesis. For example, CNS stab wound-induced
neuroinflammation appeared to prevent spongiform neu-
ropathology in the face of significant parenchymal infec-
tion (including microglial) by the highly neurovirulent
virus FrCasE [15]. Furthermore, spinal cord slice culturesRetrovirology 2006, 3:26 http://www.retrovirology.com/content/3/1/26
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Characterization of FrCasE-, Fr57E- or mock-infected primary microglia Figure 1
Characterization of FrCasE-, Fr57E- or mock-infected primary microglia. Panel A shows the basic proviral struc-
tures of the viruses employed in this study. The env genes from the NV CasBrE (clone 15-1) and NN Friend virus clone Fr57 
were introduced into the background of the Friend virus clone FB-29 to generate FrCasE and Fr57E/F43, respectively. These 
chimeric viruses differ only in their env genes. The two Fr57 env containing constructs (Fr57E and F43) differ by the restriction 
sites used for env introduction, however, no amino acid coding differences exists between the two clones. SD = splice donor; 
SA = splice acceptor. Panel B shows immunostaining of microglia isolated from mixed glial cultures to assess cell morphology, 
the extent of virus infection, and cell purity. The upper two panels show FrCasE-infected (left) and mock-infected (right) cells, 
stained with the CasBrE Env-specific monoclonal antibody 667. The lower panels show dual staining of Fr57E-infected microglia 
for Friend Env protein (left, red), and the macrophage/microglial marker Mac-1 (right). While virtually all the isolated cells were 
positive for virus infection and microglial markers, the level of cell surface staining varied considerably from very high (arrows) 
to very low (arrowheads) indicating significant cell surface expression heterogeneity. Importantly, no virus specific cell staining 
was observed in mock-infected controls using either antibodies to CasBrE or Friend Envs. Panel C shows Western blotting 
for Env (upper panel) and Gag (lower panel) on multiple FrCasE- (n = 3), Fr57E- (n = 4), and mock-infected (n = 3) microglial 
preparations. The right hand lane in each cell grouping shows immunoreactivity for mock-, Fr57E-, and FrCasE-infected 3T3 
fibroblasts as a control. The far right hand grouping for FrCasE-infected samples shows immunoblotting results using the Cas-
BrE Env specific monoclonal antibody 697. Note that the Env protein from microglia (Mg) is primarily a high molecular weight 
form for both FrCasE and Fr57E, whereas in 3T3 fibroblasts both high and low molecular weight species are observed. Note 
also that the Fr57 Env has a higher apparent molecular weight than the CasBrE Env protein consistent with known sequence 
and glycosylation differences. Pr65Gag is similar for Fr57E- and FrCasE-infected microglia; however, microglia expressed pr65 
gag and glycoGag while 3T3 fibroblasts expressed pr65gag and gag-pol polyprotein. Panel D shows the virus expression levels 
generated from infected microglia and mixed glial cultures over a 24 hour period. No significant differences in virus production 
were noted between FrCasE (black bars) and Fr57E (gray bars) in either microglial or mixed glial cultures, however, the differ-
ence in virus production between microglia and mixed glia were highly significant with p values of <0.01 (FrCasE-infected 
microglia, n = 4; FrCasE-infected mixed glia, n = 6; Fr57E-infected microglia, n = 4; Fr57E-infected mixed glia, n = 5). No virus 
was detected from mock-infected microglia or mixed glia and thus the data were not shown.Retrovirology 2006, 3:26 http://www.retrovirology.com/content/3/1/26
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Taqman real-time RT-PCR analysis of ER stress genes in mock-, Fr57E-, and FrCasE-infected microglia Figure 2
Taqman real-time RT-PCR analysis of ER stress genes in mock-, Fr57E-, and FrCasE-infected microglia. Panel 
A shows a gene expression comparison of FrCasE-, Fr57E- and mock-infected cultured microglia (Mg) for a subset of genes 
previously shown to be differentially expressed in the brains of FrCasE-infected mice compared to mock- and F43/Fr57E- 
infected controls [29]. Panel B shows a Western Blot for CHOP/GADD153 protein expression levels in equivalent samples 
from cultured microglia with mock, Fr57E and FrCasE virus infection, with and without 1 µM thapsigargin treatment for 24 
hours in culture. For comparison purposes equivalent samples from mixed glial cultures (1°CNS) were assayed in parallel 
(right). No differences in CHOP expression were noted between mock-, Fr57E-, and FrCasE infected microglia or 1°CNS cul-
tures, with or without thapsigargin treatment when evaluated in triplicate (not shown). Panel C shows Taqman real-time RT-
PCR analysis on enriched microglial fractions taken from mock-, F43-, or FrCasE-infected brains of IRW mice 14 dpi. RT-PCR 
was performed on three biological replicates for each gene, and each replicate was amplified in three separate reactions and 
normalized to either GAPDH or ribosomal protein S29. Viral RNA was also assessed in these samples with primers and 
probes specific for the Friend FB-29 viral background common to FrCasE and Fr57E. F4/80 message levels were used to assess 
microglial enrichment, which was greater than 50 fold. Black bars = FrCasE-infected; Gray bars = Fr57E infected; white = mock 
infected.
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infected with FrCasE failed to develop neruopathological
changes in the face of significant glial activation associ-
ated with their preparation.
Of considerable interest, a recent gene array study by Dim-
cheff et al. [29] identified the upregulation of several ER
stress genes in preclinical brains infected with the highly
neurovirulent virus FrCasE, a finding consistent with a
protein folding etiology of disease. This idea was sup-
ported by a detailed biochemical analysis examining the
interaction of NN and NV viral Env proteins with the pro-
tein folding machinery in 3T3 fibroblasts. These experi-
ments demonstrated a prolonged CasBrE Env-BiP
interaction in cells newly infected with FrCasE [30]. A dif-
ferential protein folding etiology seems highly plausible
given that we have previously observed multiple unique
CasBrE Env isoforms in the brains of FrCasE-infected mice
[31], and have observed restricted infectious virus produc-
tion in FrCasE-infected microglia in culture [32].
To assess the possibility that abnormal viral protein fold-
ing in microglia could lead to ER stress or other critical
physiological changes that contribute to neuropathogene-
sis, we undertook a comparison of gene expression
changes in microglia with and without NV (FrCasE) and
NN (Fr57E) virus infection. This was accomplished by
evaluating specific ER-stress genes noted to be changed in
vivo, as well as undertaking a broad survey of the micro-
glial transcriptome using Affymetrix™ chip based gene
arrays. These analyses strongly suggested that NV infection
of microglia does not induce either ER stress nor overt
neuroinflammatory changes, and demonstrated that
microglial infection elicits minimal gene expression
changes when a broad array of genes are surveyed. These
results further suggest that microglial-mediated, NV-
induced neurodegeneration results from either 1) the
post-transcriptional loss of a microglial paracrine or lux-
ury function, or 2) microglial dissemination of NV or NV
products to other neural cells that undergo acute cellular
changes.
Results and discussion
Protein expression and infectious virus production are 
similar in primary microglia infected by neurovirulent and 
non-neurovirulent ecotropic MLVs
In order to understand how the infection of microglia is
associated with the induction of severe acute spongiform
neurodegenerative disease, we undertook a comparison of
cultured microglia cells infected with either the NV FrCasE
or NN Fr57E, chimeric ecotropic viruses differing only in
their env genes (Figure 1A). To accomplish this, microglia
were infected in mixed glial cultures and isolated by shake
off as previously outlined [32]. Cell surface immunostain-
ing of the isolated microglial cells with monoclonal anti-
bodies directed against the respective viral Env proteins
showed that the isolated microglial cells were essentially
all positive for either FrCasE or Fr57E Env expression com-
pared to mock-infected controls (Figure 1B). These micro-
glia were checked for purity by immunostaining for Mac-
1 (CD11b; c.f., figure 1B) and F4/80 (not shown), which
indicated that the cells were greater than 98% positive,
consistent with our previous analysis of FrCasE-infected
microglia [32]. Interestingly, the level of surface Env and/
or microglial marker expression in the isolated microglia
was highly variable from cell to cell regardless of virus
infection. Nonetheless, no phenotypic differences were
noted between mock-, NN- or NV-infected microglia.
To evaluate whether virus protein expression was unique
for NN versus NV in microglia, primary microglia cultures
were analyzed for viral Env and Gag proteins by Western
immunoblotting as shown in figure 1C. Comparison of
Env proteins was performed using antisera developed
against the Friend Env protein that also shows cross-reac-
tivity to CasBrE Env. This analysis (figure 1C, left side of
upper panel) showed qualitatively different Env banding
patterns for FrCasE- versus Fr57E-infected microglia, with
CasBrE Env proteins migrating at a lower apparent molec-
Microglial gene array analysis shows no global changes result- ing from NN or NV ecotropic MLV infection Figure 3
Microglial gene array analysis shows no global 
changes resulting from NN or NV ecotropic MLV 
infection. Affymetrix 430A chips were used to assess global 
changes associated with infecting primary microglial cells with 
either Fr57E or FrCasE. Present/Absent calls were based on 
analysis using Microarray Suite 5.0 from Affymetrix. Aqua 
bars = Totals for all microglial arrays (n = 15); black = 
FrCasE-infected (n = 5); gray = Fr57E-infected (n = 5); white 
= Mock-infected.
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ular weight. This observation is consistent with known
differences in the primary amino acid sequences and gly-
cosylation sites of the CasBrE and Friend Env proteins
[33]. Importantly, the primary Env protein species
observed for both FrCasE and Fr57E infected microglial
cultures was a high apparent molecular weight form of
Env (gpr85) consistent with precursor protein, rather than
the processed form (gp70) noted in 3T3 cells. This result
suggests that Env protein processing differs between
microglia and fibroblasts, a finding analogous to that pre-
viously noted when FrCasE-infected microglia and mixed
glia were compared [32]. Western blotting with the Cas-
BrE-Env specific antibody 697 (figure 2C, upper panel,
right side) confirmed that the predominant CasBrE Env
species in microglia was indeed a slowly migrating protein
corresponding to the Env precursor protein. Despite the
apparent size differences between FrCasE and Fr57E Envs,
both Env proteins appear to be efficiently expressed and
readily trafficked to the cell surface, as shown by the
immuonflourescence staining analysis (figure 1B, left
panels). The relative levels of Env protein being expressed
in the various cultures appeared to be somewhat variable
in contrast to the levels of pr65gag (see below), which
were more consistent between cultures. However, given
that the relative Env expression levels were variable on dif-
ferent cells in the same culture (e.g., figure 1B), this find-
ing was not particularly surprising.
Gag immunoblotting (figure 1C, lower panel) showed the
presence of glyco-gag and pr65gag expression in all
FrCasE- and Fr57E-infected microglia, at levels that did
not differ significantly between equivalent cell extracts.
The detection of proteolytically processed p30gag was
negligible in all the microglial samples evaluated (not
shown), suggesting that little virus maturation was occur-
ring within the microglia for either NN or NV. Proteolytic
gag processing may have been expected given that we have
previously demonstrated that FrCasE infection of micro-
glia results in intracellular budding of viral particles [32]
consistent with multi-vesicular body (MVB) budding in
macrophage cell types. Interestingly, the Gag protein
expression pattern in microglia differed from that noted
in 3T3 cells, where in addition to pr65, higher molecular
weight immunoreactive species were noted. These gag
proteins most likely corresponded to Gag-pol precursor
proteins. We also observed some minor cross reactive
bands in mock-infected 3T3 cells which could indicate the
expression of endogenous retroviral sequences; however,
no such cross reactive proteins were noted in the mock-
infected microglia.
To examine whether the NN- and NV-infected microglia
generated infectious virus, culture supernatants were
taken from primary cultures 24 hours post microglial cell
isolation, and evaluated by virus titration assay. Virus tit-
ers were compared to that arising from the mixed glial cul-
tures from which the microglia were originally isolated. As
shown in figure 1, panel D, both FrCasE- and Fr57E-
infected microglia consistently yielded low virus titers,
while mixed glial cultures yielded titers at least 2 logs
higher. Examination of the mixed glial cultures by indirect
immunofluorescence microscopy demonstrated the pres-
ence of abundant mature and immature astrocytes
(GFAP+), nestin+ cells, neurofilament 68+ cells, and a few
oligodendroglia (olig 2+ and galactocerebroside+) and sig-
nificant microglia (RCA-1+, Mac-1+, F4/80Lo), all of which
showed coincident expression of the Env from the infect-
ing virus. It is not known whether virus production differs
between the different cell types present within the mixed
glial cultures. Nonetheless, these results indicate that the
env sequence differences between the Fr57E and FrCasE
did not dramatically influence virus production in either
microglia or mixed glial cultures, and suggests that infec-
tious MLV production by microglia is generally inefficient
compared to other neural cell types in culture.
Transcriptional profile comparison between mock-, Fr57E-  and FrCasE-infected microglia identifies a very small number  of differentially expressed genes Figure 4
Transcriptional profile comparison between mock-, 
Fr57E- and FrCasE-infected microglia identifies a 
very small number of differentially expressed genes. 
Average normalized expression levels for the genes and ESTs 
represented on the Affymetrix 430A mouse chip were com-
pared for each condition and plotted as pairwise compari-
sons. Panel A shows comparisons between MLV – infected 
and mock-infected control microglia. Note that very few 
genes with normalized intensity values >100 were found off 
the diagonal (which represents equal expression). Panel B 
shows a comparison between microglia infected with the 
non-neurovirulent virus Fr57E and the highly neurovirulent 
virus FrCasE. The identification of a few differentially 
expressed genes (circled) is provided. A complete listing of 
the differentially expressed genes is provided in tables 2-4.Retrovirology 2006, 3:26 http://www.retrovirology.com/content/3/1/26
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Analysis of ER stress gene expression in NV- and NN-
infected microglia
Given that microglia constitute the primary target for eco-
tropic MLVs in the CNS, we were interested in extending
previous findings of Dimcheff et al. indicating that NV
FrCasE infection in the CNS induces several ER stress
genes when compared to the isogenic NN Friend clones
F43 [29] and Fr57E. Because ER stress genes were directly
induced in FrCasE-infected NIH 3T3 cells in culture, we
examined whether similar ER stress gene induction was
occurring in infected primary microglial cells in culture.
To accomplish this we assessed the expression levels of six
different genes that were previously observed to be altered
in the brains of FrCasE-infected animals. Four of these
genes, BiP, CHOP, Calreticulin and grp58, are known to
be specifically associated with ER stress.
As shown in figure 2, panel A, no induction of the ER
stress genes BiP, CHOP, calreticulin or Grp58 was
observed in FrCasE-infected microglial cultures when
compared with mock or Fr57E-infected cells. While Grp58
showed a trend toward elevation, this observation was not
statistically significant. Both FrCasE- and Fr57E-infection
of microglia resulted in a significant decrease in CHOP
message expression, however, the importance of this
decrease is not clear. Examination of two other genes
noted to be increased early in FrCasE-infected mouse
brains, C1qa and p21, did not show statistically different
expression in FrCasE- versus Fr57E infected cells. Interest-
ingly, complement component C1qa was elevated in both
FrCasE and Fr57E-infected microglia, suggesting the pos-
sibility that MLV infection could mildly stimulate these
cells. However, F4/80 message expression, a clear indica-
tor of microglial activation, was not different between
FrCasE-, Fr57E- and mock-infected cells.
One possible explanation for the absence of ER stress gene
expression after NV infection was that the microglial iso-
Table 1: Survey of Highly Expressed Genes1in Freshly Isolated Microglia ± MLV Infection
Ribosomal/protein sythesis genes:
L31, 10, S27a, L38, L41, L35, S23, L23, L35a, S28, L3, L7a, S3, L27a, S6, S4, S3a, S29, S18, S17, S16, S12, L5, L37a, L26, L13, L13a, L18, L24, S8, S14, 
L12, L29, L30, S20, S11, S24, S8, S19, L7, L21; Translation elongation factor 1α1, Laminin receptor.
Cytoskeletal/extracellular matrix genes:
Non-muscle beta actin, Actin-like gene, Vimentin, Alpha-tubulin, Thymosins β4 and β10, Fibronectin, Secreted phosphoprotein 1.
Metal ion homeostasis:
Metallothionen 1, Ferritin light chain, Ferritin heavy chain, Transferrin.
Protein folding, stress and turnover:
Heat shock proteins 8, 1; Calreticulin; Peroxiredoxins; Ubiquitins C, B, & A52; Cathepsins D, B, H, L, and Z.
Metabolism genes:
Aldo-keto reductase, non-neuronal enolase, Aldolase, Lactate dehydrogenase, Phosphoglycerate kinase 1, Prosaposin, Lipoprotein lipase.
Antiapoptotic genes:
Translationally controlled tumor protein 1
Signaling:
Granulin, TYRO Protein tryrosine kinase binding protein
Immune/macrophage-related genes:
CD9, CD14 (LPS receptor), CD53 (Ox 44), CD68 (Macrosialin), CD164, CD81, CD47, CD44, CD24, Toll-like Receptor 2, Galactose binding 
lectin, Interleukin-18, CSF-1 receptor, Macrophage expressed gene 1, Histocompatibility locus 2D, β2-microglobulin, C-type lectin, Tumor growth 
factor-beta greceptor, Lyphocyte cytosolic protein, Tumor necrosis factor-αlpha, Complement C1q, Chemokine ligand 6. Macrophage scavenger 
receptor, Fc Receptors for IgG and IgE, Lymphotaxin, Macrophage inflammatory protein-1αlpha, Macrophage inflammatory protein -1γamma, 
Macrophage migration inhibiting factor, LAMP-1, Lysozyme eosinophil-associated RNAse.
Other nervous system genes:
Apolipoprotein E, Amyloid beta precursor-like protein, Amyloid βeta precursor protein, Spinocerebellar ataxia gene, Synapsin 1, Endothelin 
receptor, S100 (callizzarin), Nieman-Pick type C2.
1. The genes listed include the top 1% of all transcripts with present calls, plus selected genes from the next 5% of the most abundant transcripts 
observed in all 15 arrays. The selected genes were chosen based on their previous documentation as hematopoietic/macrophage/immune cell 
markers and/or association with the CNS or neurodegenerative disease. For a complete list of gene transcript expression levels, probe sets, and 
genebank accession numbers please refer to supplemental information found at EMBL-EBI, accession E-MEXP-459 and in the additional file 
accompanying this paper.Retrovirology 2006, 3:26 http://www.retrovirology.com/content/3/1/26
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lation procedures employed resulted in elevated ER stress
levels that could obscure detection of any virus-induced
changes. To examine this possibility, microglia, with and
without NN and NV infection, were treated with 1 µM
thapsigargin, a known inducer of ER stress, followed by
examination of CHOP protein expression by immunob-
lotting. As shown in figure 2B, CHOP immunoreactivity
was not observed in primary microglial cultures, regard-
less of whether they were infected with NN or NV. In con-
trast, all microglial cultures treated with thapsigargin
showed readily detectable CHOP immunoreactivity after
24 hours of exposure. As previously observed by Yagi and
coworkers, the thapsigargin-treated microglia underwent
transformation from a somewhat amoeboid to a highly
ramified morphology [34]. Comparison of CHOP expres-
sion between isolated microglia and mixed glial cultures
showed that constitutive CHOP expression levels were
much higher in the mixed glia, and could be further ele-
vated by thapsigargin treatment. As with the microglia, no
differences in CHOP expression was noted between
mock-, NN- and NV-infected mixed glial cultures (not
shown). The lack of a detectable ER stress response in
either the microglia or mixed glia in response to NV infec-
tion suggests that any NV-induced cellular ER stress
response may be a transient rather than a persistent
change in cell physiology. The high basal CHOP signal in
the mixed glia, however, could obscure any NV-induced
change if it is relatively small.
To evaluate whether NV virus infection of microglia
induced ER stress only in the context of the brain, micro-
glial enriched fractions derived from FrCasE-, F43- and
mock-infected mice (14 dpi) were examined by Taqman
real-time quantitative RT-PCR to assess BiP and CHOP
RNA expression levels. As shown in figure 2B, no signifi-
cant differences were noted between NV-, NN-, and mock-
infected microglia. Microglial enrichment from the brain
was determined to be greater than 50 fold as assessed by
F4/80 message levels comparing enriched fractions to
whole brain samples run in parallel. Interestingly, the
microglial enriched brain fractions showed higher viral
RNA levels for F43 than FrCasE, while microglia in culture
data showed higher message levels for FrCasE than Fr57E.
The differing results from ex vivo versus cultured micro-
glia were likely reflective of the different environments or
differentiation states of the cells evaluated. Regardless of
the cellular environmental differences, neither NN nor
NV infection appeared to induce ER stress in microglia.
Why the microglia did not show ER stress in response to
NV infection as previously reported for NIH 3T3 cells [30]
and astrocytes [35,36] is not clear, however, several possi-
bilities exist. First, the lack of ER stress in NV-infected
microglia could be simply due to cellular adaptation to a
persistent infection. The original ER Stress analysis of
FrCasE in NIH3T3 cells examined acute cellular responses,
while in the current analysis we examined microglial cells
more than a week after the mixed glial cultures were
exposed to virus. Second, it is possible that microglia are
less susceptible to virus-induced ER stress than other cell
types due to their extensive ER network and high basal cal-
reticulin levels (see Table 1 below and [37]). Alternatively,
since retrovirus budding in macrophages occurs in MVBs
rather than at the plasma membrane, MVB virus assembly
may preclude the development of ER stress. Fourth, as
shown in figure 1, infectious virus expression in microglia
was much lower than that observed in the mixed glial cul-
Taqman real-time RT-PCR validation assessment of micro- glial genes identified in Fr57E versus FrCasE gene arrays Figure 5
Taqman real-time RT-PCR validation assessment of 
microglial genes identified in Fr57E versus FrCasE 
gene arrays. Panel A shows qRT-PCR analysis of RNA from 
two independent microglial culture experiments assaying 
three separate cultures in triplicate for SIGIRR, exosome 
component 4 (Exosc4), and Riken cDNA 1810008K03 gene 
(ChaC). These cultures were distinct from those used for 
microarray analysis. Panel B shows qRT-PCR analysis of 
SIGIRR RNA obtained from microglia isolated from the 
brains of virus-infected and uninfected mice. FrCasE- infected 
(black); F43- infected (gray); mock-infected (white)
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Table 2: Differentially Expressed Genes between Mock- and Fr57E Non-neurovirulent Virus-infected Microglia
Mock-infected Fr57E-infected
probe set gene Accession Function/processa mean SE Callb mean SE Callb fold change
1425923_at *neuroblastoma myc-related oncogene 
1
M36277 Transcription/cell cycle control 6.96 27.32 A 2189.17 113.3 P 314.68
1425131_at *protein tyrosine phosphatase, non-
receptor type 5
U28216 Tyrosine phosphatase -101.71 12.11 A 220.58 45.16 A 220.58
1456182_x_a
t
*melanoma antigen (env polyprotein) BB795191 retroviral envelope protein 39.08 9.27 A 1057.46 164.85 A 27.06
1427694_at *gonadotropin releasing hormone 
receptor
L28756 G-protein coupled receptor 26.1 6.83 A 236.32 27.04 A 9.05
1429212_a_at *RIKEN cDNA 1700008D07 gene 
(testis cDNA)
AK005758 Inflammatory response 27.15 6.67 A 200.55 23.75 A 7.39
1422720_at *ISL1 transcription factor, LIM/
homeodomain, (islet-1)
NM_021459 Transcription factor/development 28.05 13.62 A 204.31 17.73 A 7.28
1431213_a_at *RIKEN cDNA 1300007C21 gene 
(vaginal cDNA)
BG297038 Retrovirus-related POL polyprotein 43.54 12.85 P 234.29 93.25 P 5.38
1455788_x_a
t
*Polymerase (DNA-directed), delta 
interacting protein 3
BB495487 Nucleic acid binding 168.36 116.73 P 832.13 40.86 P 4.94
1452288_at *expressed sequence BB128963 
(neonatal cerebellum)
BG071933 Similar to myotubularin related 
proteins
64.79 36.28 mA 284.96 32.16 mA 4.4
1450824_at *patched homolog NM_008957 Hedgehog receptor 82.11 17.51 A 237.39 24.44 A 2.89
1450610_at *urocortin NM_021290 Neuropeptide signaling 66.48 25.27 A 185.56 23.69 A 2.79
1424887_at kelch domain containing protein 4 BC012312 No annotation 107.6 19.51 mA 254.85 59.56 mA 2.37
1460469_at *tumor necrosis factor receptor 
superfamily, member 9
BM250782 Receptor/defense response 148.29 28.95 A 311.04 32.32 mA 2.1
1451107_at *TBC1 domain family, member 22a BC023106 GTPase activator activity 296.8 27.95 mA 610.17 47.13 mA 2.06
1449036_at #Ring finger protein 128 AK004847 (-) regulation of cytokine synthesis 180.46 26.71 P 292.69 27.22 P 1.62
*Genes with asterisks showed differential expression in both Fr57E- and FrCasE-infected microglia when compared to mock-infected microglia (see table 3).
Bolded genes are those that show differential expression only in Fr57E-infected microglia compared to mock-infected microglia.
# This gene was included based on statistical differences (p < 0.05) and its potential immune modulatory function, despite falling below the arbitrary two-fold cut off threshold.
a- Function/process was determined by gene ontology information provided through the Affymetrix NetAffx Analysis Center and its links to PubMed, EMBL, etc.
b-A = Absent call in 5/5 arrays; mA = Absent calls in 3–4/5 arrays; P = Present call in 5/5 arrays; mP = present calls in 3–4/5 arraysRetrovirology 2006, 3:26 http://www.retrovirology.com/content/3/1/26
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tures from which the microglial cells are derived. Whether
this is due to lower cellular viral proteins levels is not
clear, however, even fewer higher order structures may
prevent the induction of ER stress in this cell type.
Nonetheless, persistently infected microglial cells like
those investigated here, are fully capable of inducing
spongiform neuropathological changes when trans-
planted into susceptible mouse brains [15]. While it is
possible that microglia tin situ are susceptible to NV-
induced ER stress, preliminary experiments by Dimcheff
and Portis have not observed CHOP expression in associ-
ation with microglia in FrCasE-infected brains (personal
communication). A more likely possibility is that infected
microglia may simply serve to disseminate virus to other
cell types, which undergo acute ER stress changes upon
infection. Given that we observed higher basal levels of
CHOP expression in the mixed glial cultures compared to
microglia, it is likely that non-microglial cells are respon-
sible for CNS ER stress. This idea is consistent with results
from Liu et al. showing ER stress in astrocytes infected
with the NV ts1 [36].
Gene array profiling of NN and NV infected microglia
Because we observed no overt differences in microglial
morphology or ER stress gene expression upon infection
with NN or NV we undertook a transcriptional profile
comparison of the FrCasE-, Fr57E- and mock-infected
microglial cultures to identify gene expression changes in
microglia that might provide insight as to how FrCasE
induces neurodegeneration. This was carried out using
Affymetrix 430A mouse gene chips possessing more than
22,000 probe sets, capable of surveying more than 14,000
well characterized murine genes and ESTs. The complete
normalized data set for this analysis is provided as an
additional file (see Additional file 1), and the detailed
experiments were archived at the European Molecular
Biology Institute, European Bioinformatics Institute,
Microarray Informatics, MIAMExpress website [38].
To examine whether any global gene expression changes
occurred in cultured microglia in response to MLV infec-
tion we comparing the number of transcripts being
expressed under the different virus expression conditions.
As shown in figure 3, approximately 45% of the genes and
ESTs represented on the chips were called present in the
microglial cultures. Importantly, no significant differ-
ences in the number of present-absent calls were observed
between FrCasE-, Fr57E- and mock-infected primary
microglia (5 separate arrays per infection condition).
Analysis of the highly expressed genes in all the arrays
(Table 1) provided an expression signature for cultured
mouse microglia. The abundant genes included a number
of hematopoietic/macrophage/immune cell genes, with-
out evidence of macroglial and neuronal markers. The
expression profiles obtained were consistent with the
microglial signature previously reported for rat microglia
using early Affymetrix gene chips [37,39] however, the
number of genes reported to be expressed by the murine
microglia used herein was dramatically elevated com-
pared to the previous analysis of rat microglia. Whether
this is the result of including GM-CSF in the growth
medium to stimulate microglial proliferation, the
expanded number of probe sets represented on the 430A
chips, increased sensitivity of the assay, or some other fac-
tor is not known.
To identify specific changes in microglial gene expression
resulting from infection by FrCasE and Fr57E, expression
profiles for each condition were compared to mock-
infected cells or to one another in a pair wise fashion after
normalization of the cel intensity file data for all 15
arrays. As shown in figure 4, panel A, very few genes were
observed to be differentially expressed in infected versus
uninfected cells, as indicated by the appearance of points
away from the center diagonal, which represents equal
expression. Genes that showed a greater than two fold
expression difference between groups and/or were statisti-
cally different between MLV and mock-infection are pro-
vided in Tables 2 and 3. Thirteen (13) common genes
were identified as being elevated in both FrCasE- and
Fr57E-infected microglia compared to mock-infected cells
as indicated by asterisks in Tables 2&3. When the probe
sets for these genes were evaluated for potential cross
hybridization to viral RNA, 2 exact matches were found
for neuroblastoma myc-related oncogene 1 (n-myc), and
4 and 2 exact matches for Riken cDNA 130007C21 EST
(Affymetrix probes sets 1431214_at & 1431213_a_at,
respectively) suggesting that these probe sets may be
detecting viral message. Given that the Riken cDNA
130007C21 probe set detects sequences related to retrovi-
rus POL polyprotein, this supposition seems all the more
likely. In addition to those genes with potential cross
hybridization, the melanoma antigen probe set listed in
tables 2 and 3 identifies retroviral env  gene-related
sequences, suggesting that this gene too may be an indica-
tor of retroviral infection. Of the remaining genes identi-
fied as being differentially regulated, there is no clear
indication that a specific biochemical pathway is being
altered due to either FrCasE or Fr57E virus infection of
microglia. It should also be noted that many of the genes
listed in tables 2 and 3 were called absent. Interestingly,
the MAS software calls were made despite the fact that
normalized signal intensities were well above background
(>100) using the dCHIP software. This likely represents
the differential weighting of the actual cel file intensities
for each probe pair, and raises questions regarding how
the presence of pathogen message can confound cellular
gene analysis.Retrovirology 2006, 3:26 http://www.retrovirology.com/content/3/1/26
Page 11 of 19
(page number not for citation purposes)
In addition to the 13 genes commonly upregulated by
MLV infection, Fr57E infection of microglia altered two
additional genes (bold, table 2) that were not noted when
FrCasE-infected cells were compared to mock-infected.
Similarly, FrCasE-infected microglia showed unique
expression of 4 genes not seen in Fr57E versus mock (bold
italicized, table 3). While no obvious biological implica-
tions are suggested by these differences, there remains the
formal possibility that the combination of commonly
altered and differentially altered gene expression profiles
induced by Fr57E and FrCasE infection could be responsi-
ble for differences in neuropathogenic potential of the
two viruses.
To identify gene expression differences that were exclusive
to the neurovirulent FrCasE-infected microglia, normal-
ized intensity files from FrCasE- and Fr57E-infected
microglia were compared directly as shown in figure 4B.
Remarkably, only 3 genes were observed to show statisti-
cally significant changes at a level of two-fold or greater
(Table 4). These genes included SIGIRR, Exosome compo-
nent 4, and an EST for a hypothetical protein similar to E.
coli ChaC protein (Riken1810008K03). The false discov-
ery rate was estimated by permutation of the arrays, which
showed that for 50 different permutations the number of
genes identified as meeting the same comparison criterion
was 0 for 45 (90%) of the permutations. The remaining 5
(10%) permutations identified either 2 or 3 genes. Further
investigation revealed that 2 of these 5 permutations
accounting for the 90th percentile FDR were permutations
that grouped the conditions within the same sets as con-
ceived by the experiment. The remaining 3 permutations
were from permutations in which only one of the 5 arrays
was swapped between groups. Thus, the analysis strongly
suggests that 2 of the 3 genes identified are likely to be
indicative of real changes.
Assessment of gene expression changes in microglia by 
quantitative real-time PCR
To assess whether the 3 gene expression changes between
FrCasE- and Fr57E-infected microglia observed in the
array experiments could be validated by Taqman® qRT-
PCR, we performed two independent experiments exam-
ining triplicate mock-, Fr57E- and FrCasE-infected micro-
glial cultures. The results from these experiments are
depicted in figure 5A. Analysis of SIGIRR message demon-
strated that mRNAs for this gene were clearly elevated in
FrCasE-infected versus mock-infected cells. In addition,
FrCasE-infected microglia showed elevated SIGIRR mes-
sage expression over Fr57E-infected cells in the first exper-
iment (left panel), with more equivocal elevation
observed in the second experiment (right panel). These
results suggested a trend towards SIGIRR message eleva-
tion in response to infection by NV. In contrast, examina-
tion of Exosc4 message showed no significant differences
in gene expression in the two experiments performed.
While this result differs from that noted by gene array, the
gene array results were based on probe intensity values
ascribed to this gene by the dChip software. However, this
gene was called absent (Table 4) by the Affymetrix MAS
analysis software, suggesting that ambiguity existed with
regard to whether the PM/MM probe pair intensity values
demonstrated appropriate specificity for the Exosc4 gene.
Analysis of message for Riken Gene 1810008K03 (ChaC-
like protein {ChaC}), showed a statistical difference
between mock and both virus-infected samples in one
experiment, however, there was no difference between
message levels in FrCasE and Fr57E-infected microglial
cultures in either of the two experiments undertaken.
These findings could be due to the relatively low abun-
dance of this message in the microglia (see signal intensity
values in Tables 3&4) or its inherent variability between
cultures (this gene was called present 3/5 times in Fr57E-
infected cultures and was absent 3/5 times in FrCasE-
infected cultures). Ultimately, these findings suggest that
any changes in this gene are unlikely to play a role in dis-
rupting microglial physiology. These qRT-PCR validation
results suggest that only the SIGIRR changes identified by
the gene array screen may represent a consistent gene
expression change induced by NV in culture. The identifi-
cation of Exosc4 and ChaC likely represent either false
positives (see discussion above), or genes that are only
variably affected by NV and NN infection. Given that CNS
infection by FrCasE invariably results in neurodegenera-
tion, neither Exosc4 or ChaC represent a likely candidate
gene involved in neuropathogenesis.
Because SIGIRR has been reported to be capable of down
modulating Toll-like receptor responses [40-42] and
could potentially have a negative effect on various consti-
tutive microglial CNS support functions, we attempted to
confirm the microglial mRNA changes at the protein level.
In Western blotting experiments using two different com-
mercially available antibodies to SIGIRR, we were unable
to show detectable SIGIRR protein in 3 independent
microglial preparations for each infection condition
employed (not shown). These results suggested that
SIGIRR protein expression levels were probably quite low
in microglia, however, because no positive control was
used to assess the sensitivity of the reagents employed, the
value of the immunoblotting experiments remain in ques-
tion.
To assess whether SIGIRR message levels might be altered
in vivo, we undertook qRT-PCR on RNA isolated from
enriched microglial fractions from infected and unin-
fected mouse brains at 14 days post virus inoculation, as
outlined above for ER stress genes. No differences in
SIGIRR expression levels could be documented (figure
5B). Thus, while the RT-PCR results generally support theRetrovirology 2006, 3:26 http://www.retrovirology.com/content/3/1/26
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elevation of SIGIRR message in FrCasE-infected microglial
in culture, its relevance to gene/protein expression in vivo
is in question, and thus provides little insight into a pos-
sible role of SIGIRR in neuropathogenesis.
The major picture emerging from this investigation is a
veritable lack of significant gene expression changes
induced in microglia in response to infection by the
highly neurovirulent FrCasE retrovirus. This finding is
particularly remarkable, given the correlation of NV-
infected microglia with acute, progressive CNS pathology
in the brain and spinal cord. We recognize the formal pos-
sibility that because the gene chips employed survey only
about half of the total genes encoded in the murine
genome, gene expression changes critical to the induction
of neuropathogenesis may have been missed. However,
the chips employed represent all the major cellular path-
ways heretofore characterized, and thus it is not clear how
potential changes in the expression of unknown genes
could so severely affect CNS function without affecting
the expression of one or more of the 14,000 microglial
genes represented on the gene chips employed. The possi-
bility also exists that primary microglial cultures or micro-
glia enriched from infected brains, may not faithfully
replicate critical microglial paracrine interactions with
susceptible neurons and/or macroglia that occurs in vivo
and contribute to disease. Unfortunately,, the experi-
ments necessary to critically addressi this issue are beyond
the scope of this study. Nonetheless, the models
employed constitute a reasonable starting point for con-
ducting such a broad molecular screen without complica-
tions of trace interfering contaminants, and are a logical
extension of the findings from cultured fibroblasts, which
are not present in the infected CNS. Importantly, the cur-
rent findings showing a lack of gene expression changes in
microglia in response to NV infection are consistent with
our previous analyses that have failed to show evidence of
biochemical (e.g., iNOS, esterases, apoptosis, proteases,
phosphorylations) or inflammatory changes (e.g., altered
expression of MHC, CD11b, CD80, CD86, IL-1, IL-6, TNF
alpha, F4/80, etc.) in microglia in vivo as early compo-
nents of the pathogenic process (cf [7]). These metobolic
analyses were by no means comprehensive, however, it
was hoped that the gene array screen might help to narrow
the focus on specific pathways altered in the major
infected cell type that contributes to disease. Perhaps most
importantly, this analysis testifies to the facility of retrovi-
ruses to infect and persist in the major immune compo-
nent of the host CNS without inducing significant gene
expression changes, and thus may allow them to become
a veritable "Trojan Horse" that ultimately destroys the
CNS motor system, and ultimately the host.
Conclusion
In this paper we have investigated how the infection of
microglia by a highly neurovirulent murine retrovirus,
FrCasE, could alter their physiology to precipitate the pro-
found, acute, spongiform neurodegenerative changes
observed in the CNS motor systems of NV-infected mice.
To accomplish this, we undertook a basic virological
assessment coupled with qRT-PCR and Affymetrix gene
array analyses ex vivo to evaluate ER stress and or other
potential pathways that could be induced by FrCasE. Our
results indicated that FrCasE infection of microglia does
not induce detectable ER stress in these cells, and thus is
unlikely to account for the ER stress changes observed in
the brains of NV-infected IRW mice [29]. CNS ER stress is
therefore likely to be the result of FrCasE infection of
some other CNS cell type, or is the product of NV-induced
neurodegeneration.
Our gene array analysis of over 14,000 known genes and
ESTs showed that in vitro infection of microglia by either
FrCasE or Fr57E results in only a very small set of gene
expression changes in these cells. The gene sets identified
were similar, but not identical, for NV and NN, raising the
possibility that disease could be mediated by unique gene
combination differences. However, of the three specific
gene expression differences noted between FrCasE and
Fr57E infected microglia by array analysis, we could only
provide support for differences in SIGIRR in similar qRT-
PCR experiments. Furthermore, the SIGIRR gene failed to
exhibit expression differences in microglia isolated from
NV-, NN-, and mock-infected mouse brains, raising doubt
as to its involvement in the induction of neuropathogen-
esis. Perhaps the most remarkable result from these stud-
ies was the lack of overt gene expression changes in NV-
infected microglial cells testifying to the stealth of the NV
in CNS microglia. The lack of perturbation may explain
why MLVs are so readily found in these cells.
Given the virtual absence of microglial gene expression
changes noted upon infection by the highly neurovirulent
virus FrCasE when assayed ex vivo, we conclude that if
microglial infection does indeed play a central role in
spongiform neurodegenerative disease induction, then it
must be acting through one of the following possible
ways. First, NV could affect microglial gene expression
that uniquely occurs within the CNS, or was not repre-
sented in our gene array survey. Alternatively, NV could
affect microglial physiology at a post-transcriptional or
proteomic level. Finally, NV-infected microglia may sim-
ply serve as highly quiescent conduits for dissemination
of neuropathogenic virus to other CNS cell types whose
infection induces acute alterations such as ER stress,
spongiform neuropathology and loss of neuronal func-
tion. Distinguishing between these possibilities will likely
require direct in vivo analyses.R
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Table 3: Differentially Expressed Genes Between Mock- and FrCasE-infected Microglia
Mock-infected FrCasE-infected
probe set gene Accession Function/processa mean SE Callb mean SE Callb fold change
1425923_at *neuroblastoma myc-related oncogene 1 M36277 Transcription/cell cycle control 6.96 27.32 A 2239.4 116.8 mP 321.9
1425131_at *protein tyrosine phosphatase, non-
receptor type 5
U28216 Tyrosine phosphatase -
101.71
12.11 A 235.6 48.34 A 235.6
1431214_at *RIKEN cDNA 1300007C21 gene 
(vaginal cDNA)
BG297038 Retrovirus-related POL polyprotein -14.82 11.41 A 146.69 79.6 mP 146.69
1456182_x_at *melanoma antigen BB795191 Viral envelope related 39.08 9.27 A 939.13 74.66 A 24.03
1431213_a_at *RIKEN cDNA 1300007C21 gene(vaginal 
cDNA)
BG297038 Retrovirus-related POL polyprotein 43.54 12.85 P 571.78 257.8 P 13.13
1427694_at *gonadotropin releasing hormone 
receptor
L28756 G-protein coupled receptor 26.1 6.83 A 218.05 14.59 A 8.35
1422720_at *ISL1 transcription factor, LIM/
homeodomain, (islet-1)
NM_021459 Transcription factor/development 28.05 13.62 A 215.44 14.84 A 7.68
1429212_a_at *RIKEN cDNA 1700008D07 gene (testis 
cDNA)
AK005758 Inflammatory response 27.15 6.67 A 187.81 39.86 A 6.92
1455788_x_at *Polymerase (DNA-directed), delta 
interacting protein 3
BB495487 Nucleic acid binding 168.36 116.7 P 919.68 61.16 P 5.46
1452288_at *expressed sequence BB128963 
(neonatal cerebellum)
BG071933 Similar to myotubularin related proteins 64.79 36.28 mA 352.56 23.76 mA 5.44
1449163_at single Ig IL-1 receptor related protein NM_023059 Immune reponse inhibition 75.17 22.22 mA 405.05 69.42 mP 5.39
1425260_at albumin 1 BC024643 Carrier protein 32.31 11.17 A 136.36 15.27 A 4.22
1450610_at *urocortin NM_021290 Neuropeptide signaling 66.48 25.27 A 208.42 18.38 A 3.13
1450824_at *patched homolog NM_008957 Hedgehog receptor 82.11 17.51 A 245.79 33.45 A 2.99
1437712_x_at exosome component 4 AV212315 exonuclease/RNA processing 347.13 128.5 A 988.22 288.1 A 2.85
1451107_at *TBC1 domain family, member 22a BC023106 GTPase activator 296.8 27.95 mA 605.2 52.13 mA 2.04
1460469_at *tumor necrosis factor receptor 
superfamily, member 9
BM250782 Receptor/defense response 148.29 28.95 A 297.71 36.4 mA 2.01
1451382_at RIKEN cDNA 1810008K03 gene, ChaC 
1
BC025169 ChaC, cation transport regulator-like 209.65 14.12 mP 35.33 54.81 mA -5.93
*Genes with asterisks are those that showed differential expression in both Fr57E- and FrCasE-infected microglia when compared to mock-infected microglia (see table 2).
Bolded italicized genes are those that show differential expression only in FrCasE-infected microglia compared to mock-infected microglia.
a- Function/process was determined by gene ontology information provided through the Affymetrix NetAffx Analysis Center and its links to PubMed, EMBL, etc.
b-A = Absent call in 5/5 arrays; mA = Absent calls in 3–4/5 arrays; P = Present call in 5/5 arrays; mP = present calls in 3–4/5 arrays. Call determined by Microarray suite 5.0 (Affymetrix) SE-
Standard Error.Retrovirology 2006, 3:26 http://www.retrovirology.com/content/3/1/26
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Methods
Mice, virus and inoculations
All mice used in this study were Inbred Rocky Mountain
White mice that were bred and raised in either the Com-
parative Medicine Units at NEOUCOM or at the Rocky
Mountain Laboratories. All experimental procedures
employed were approved by either the NEOUCOM Insti-
tutional Animal Care and Use Committee or the Rocky
Mountain Laboratories Animal Care and Use Committee.
Mice were infected within 48 hours of birth by intraperi-
toneal injection of approximately 30 µl of FrCasE, Fr57E,
or F43 virus stocks; or for mock infections, with tissue cul-
ture media alone. Mock- and virus-infected mice were
euthanized under deep isoflurane anesthesia at either 14
days post inoculation (dpi) for harvesting CNS microglia.
Virus stocks were prepared by transfection of virus-encod-
ing plasmids into either NIH 3T3cells or Mus dunni
fibroblasts. These stocks contained between 5 × 106 and 1
× 107 focus-forming units of infectivity per ml (ffu/ml).
The viruses used herein were all based on the Friend virus
clone FB-29 background, into which was inserted either
the env genes from the NV CasBrE virus clone 15-1 [43] or
the NN Friend clone 57 [22] (see figure 1A). Fr57E and
F43 viruses are ostensibly the same virus since both con-
tain the env gene from Friend virus clone 57 inserted into
the background of the Friend virus clone FB-29 [22].
Fr57E differs from F43 in being co-linear (unpermutted);
it has a pSP72 vector background, rather than pUC19; and
was engineered using the BsaAI site, rather than the NdeI
site for introduction of the Fr57 env gene into the FB29
background. While the NdeI-BsaAI region contains 7
nucleotide differences, none of these result in amino acid
changes within pol.
Virus titration assays were performed as previously
described on NIH 3T3 cells [44].
Primary microglial cultures and microglial enrichment 
from the CNS
Microglial cultures were prepared from P0 neonatal IRW
mouse brains minus the cerebella and olfactory bulbs that
had been freed of meninges as previously described
[32,45]). Briefly, brains were triturated, passed through a
70 µm nylon mesh filter, treated for 5 minutes at 37°C
with 0.25% Trypsin/1 mM EDTA, and then quenched by
the addition of newborn calf serum (Hyclone) to 2%.
Mixed CNS cells were plated in T75 Corning flasks
(approximately 1 brain equivalent per flask) in Advanced
DMEM (Life Technologies) supplemented with 5% fetal
bovine serum, 4 mM glutamine, penicillin and streptomy-
cin (DMA5). After 7–10 days in culture, when the mixed
glia reached approximately 50% confluence, the cultures
were infected with FrCasE or Fr57E MLVs or mock
infected at a MOI of ~1 in the presence of 8 µg/ml of poly-
brene. When the cultures reached confluence, medium
was changed to DMA5 supplemented with 0.5 ng/ml GM-
CSF to enhance the proliferation of microglia. When
abundant phase bright cells could be observed over the
mixed glial monolayer, microglia were isolated by shake
off, plated on fresh 10 cm Corning tissue culture plates for
1 hour, and washed 3 times with phosphate buffered
saline (pH 7.4) to remove non-adherent cells. Parallel cul-
tures of adherent cells were routinely checked for purity
using antibodies directed against F4/80, and Mac-1
(CD11b), by indirect immunofluorescence (figure 1B) as
previously outlined [32]. The presence of virus infection
was determined by staining microglia with monoclonal
antibodies that were specific to either CasBrE Env (697
Table 4: Differentially Expressed Genes Between Fr57E- and FrCasE-infected Microglia
Fr57E-infected FrCasE-infected
probe set gene Accessio
n
Function/
processa
mean SE Callb mean SE Callb fold 
change
1449163_a
t
single Ig 
IL-1 
receptor 
related 
protein
NM_0230
59
Immune 
reponse 
inhibition
72.42 28.86 mA 405.05 69.42 mP 5.39
1437712_x
_at
exosome 
compone
nt 4
AV212315 exonucleas
e/RNA 
processing
352.67 101 A 988.22 288.1 A 2.8
1451382_a
t
RIKEN 
cDNA 
1810008K
03 gene, 
ChaC 1
BC025169 ChaC, 
cation 
transport 
regulator-
like
186.12 19.03 mP 35.33 54.81 mA -5.27
Bolded italicized genes are those that show differential expression in FrCasE-infected microglia when compared to mock- and Fr57E-infected 
microglia.
a-Function/process was determined by gene ontology information provided through the Affymetrix NetAffx Analysis Center and its links to 
PubMed, EMBL, etc.
b-A = Absent call in 5/5 arrays; mA = Absent calls in 3–4/5 arrays; P = Present call in 5/5 arrays; mP = present calls in 3–4/5 arraysRetrovirology 2006, 3:26 http://www.retrovirology.com/content/3/1/26
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and 667 [46]) or Friend Env (48, 500, & 720 [47,48]). All
microglial cultures used were determined to be greater
than 95% pure with essentially complete infection by the
appropriate virus.
Enrichment of microglia from the brains of mock-,
FrCasE- and F43- infected mice was carried out essentially
as described by Havenith et al. [49]. Brains were taken at
14 dpi; a time corresponding to peak CNS virus infection,
significant neuropathology, but prior the onset of clinical
disease. Briefly, harvested brains were minced in Dul-
becco's modified phosphate buffered saline (DPBS),
homogenized by 5–10 strokes with a loose fitting dounce
homogenizer, passed through a 100 µm nylon filter fol-
lowed by centrifugation at 400 × g for 5 minutes. After
removing the supernatant, pelleted cells were resus-
pended in 70% percoll in DPBS, and then layered beneath
DPBS and 35% Percoll layers. Gradients were centrifuged
for 45 minutes at 1000 × g. Cells were collected from the
35% percoll layer and RNA was immediately harvested as
outlined below. F4/80 message levels were used as a
marker for microglial enrichment by comparing levels in
the percoll gradient fractions with that found in whole
brain (WB) homogenates. The results indicated that this
procedure produced at least a 50-fold enrichment for
microglia cells compared to whole brain (see figure 2B).
Three separate brains for each group were analyzed.
RNA isolation and real time quantitative RT-PCR
Total RNA from primary microglial cultures was isolated
1 hour after plating microglia (outlined above) using TRI-
zol™ according to the manufacturer's instructions (Invit-
rogen). For Affymetrix array analysis, approximately 5–10
× 106 adherent microglia cells were used per isolation.
These cells were derived from a minimum of three sepa-
rate microglial cultures that had been infected in parallel.
For real time quantitative RT-PCR experiments, a mini-
mum of 3 separate cultures containing approximately 2 ×
106 adherent microglia were used. Total RNA was isolated
from microglial-enriched brain fractions using the RNeasy
mini kit as outlined by the manufacturer (Qiagen). Pre-
cipitated total RNA was stored as a pellet in 70% ethanol
at -80°C until it was solubilized for array and RT-PCR
experiments. The integrity of RNA was evaluated with an
RNA 6000 nano assay kit and Bioanalyzer 2100 (Agilent)
to visualize and compare 18S and 28S rRNA bands prior
to cDNA and cRNA probe synthesis or real-time RT-PCR.
Taqman real time RT-PCR analysis for BiP (grp78), CHOP
(GADD153), calreticulin, Grp 58, p21, C1qa, F4/80, glyc-
eraldehyde-3-phosphate dehydrogenase (GAPDH),
SIGIRR, Exosome component 4, Riken cDNA
1810008K03 (ChaC), and 18S was performed as previ-
ously outlined by Dimcheff et al. [29]. The relative quan-
tity of each target transcript was normalized to message
for GAPDH and/or ribosomal protein S29 (40S) for each
sample by amplifying GAPDH/40S simultaneously with
target genes, but in separate triplicate-reaction tubes. Data
were analyzed with ANOVA with Tukey's multiple-com-
parison test or student's t-test and a level of p =0.05 was
considered statistically significant.
Primer and probe sequences used for real-time RT-PCR are
listed 5' to 3'. F is forward strand and R is reverse.
Virus RNA gag: F-AAACCAATGTGGCCATGTCATT,
R-AAATCTTCTAACCGCTCTAACTTTCG,
probe -ATCTGGCAGTCCGCCCCGG;
CHOP(Gadd153): F - GTCCCTAGCTTGGCTGACAGA,
R-TGGAGAGCGAGGGCTTTG,
probe-CAGGGCCAACAGAGGTCACACGC;
Grp58/ERp57: F-TCAAGGGTTTTCCTACCATCTACTTC,
R-TTAATTCACGGCCACCTTCAT,
probe-CACCAGCCAACAAGAAGCTAACTCCAAAGA;
BiP (grp58): F-TCATCGGACGCACTTGGAA,
R-CAACCACCTTGAATGGCAAGA,
probe-ACCCTTCGGTGCAGCAGGACATCA;
Calreticulin: F-TTACGCACTGTCCGCCAAA,
R-GCTCATGCTTCACCGTGAACT,
probe-CGAACCCTTCAGCAATAAGGGCCAG;
Complement component C1qa: F-TCTCAGCCATTCG-
GCAGAA,
R-TGGTTGGTGAGGACCTTGTCA,
probe-AGATAACCACGTTGCCAAGCGTCATTG;
p21 (Cyclin dependent kinase inhibitor): F-TTCCG-
CACAGGAGCAAAGT,
R-CGGCGCAACTGCTCACT,
probe- CCGTTGTCTCTTCGGTCCCGTGG;
F4/80: F-TTACGATGGAATTCTCCTTGTATATCA,Retrovirology 2006, 3:26 http://www.retrovirology.com/content/3/1/26
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R- CACAGCAGGAAGGTGGCTATG,
probe- AGTCATCTCCCTGGTATGTCTTGCCTTGG; and
Single Ig IL-1 receptor related protein (SIGIRR):
F- TGAAAGATGGTCTGGCATTGG,
R- TGGCGCTGACCCAGAAGT,
probe- AATGGAAGCCACTTCAGCCTCCATGA ;
Ribosomal protein S29: F-CACGGTCTGATCCG-
CAAATAC,
R-AGCCTATGTCCTTCGCGTACTG,
Probe-TGAACATGTGCCGCCAGTGCTTC.
In addition, premade Taqman® gene expression assays
from Applied Biosystems were used to quantify message
for exosome component 4 (Exosc4; Mm00615045_g1),
Riken cDNA 1810008K03 (ChaC; Mm00509926_m1),
and GAPDH.
Affymetrix arrays
Gene array analysis, including the production of cRNA
from total microglial RNA and the generation of Cel
intensity files, was performed by Genome Explorations
(Memphis, TN) using Affymetrix 430A mouse Gene-
chips™ containing more than 22,000 probe sets represent-
ing more than 14,000 genes and expressed sequence tags
(ESTs). Total RNA was isolated as outlined above. Imme-
diately prior to cDNA synthesis, the purity and concentra-
tion of RNA samples were determined from OD260/280
readings using a dual beam UV spectrophotometer and
RNA integrity was determined by capillary electrophoresis
using the RNA 6000 Nano Lab-on-a-Chip kit and the Bio-
analyzer 2100 (Agilent Technologies) as per the manufac-
turer's instructions. First and second strand cDNA were
synthesized from 15 ug of total RNA using the SuperScript
Double-Stranded cDNA Synthesis Kit (Invitrogen) and
oligo-dT24-T7 (5'-GGC CAG TGA ATT GTA ATA CGA CTC
ACT ATA GGG AGG CGG-3') primer (PrOligo) according
to the manufacturer's instructions. cRNA was synthesized
and labeled with biotinylated UTP and CTP by in vitro
transcription using the T7 promoter-coupled double
stranded cDNA as template and the Bioarray™ HighYield™
RNA Transcript Labeling Kit (ENZO Diagnostics Inc.).
Briefly, double-stranded cDNA, synthesized from the pre-
vious steps, was washed twice with 70% ethanol and
resuspended in 22 ul RNase-free H2O. The cDNA was
incubated with 4 ul of 10X each reaction buffer, Biotin-
labeled ribonucleotides, DTT, RNase inhibitor mix and 2
ul 20X T7 RNA polymerase for 5 hr at 37°C. The labeled
cRNA was separated from unincorporated ribonucleotides
by passing through a CHROMA SPIN-100 column (Clon-
tech) and ethanol precipitated at -20°C for 1 hr to over-
night.
Oligonucleotide array hybridization and analysis
The cRNA pellet was resuspended in 10 ul RNase-free H2O
and 10.0 µg was fragmented by ion-mediated hydrolysis
at 95°C for 35 min in 200 mM Tris-acetate (pH 8.1), 500
mM potassium acetate, 150 mM magnesium acetate. The
fragmented cRNA was hybridized for 16 hr at 45°C to
MOE 430A gene chips, which detect over 22,000 murine
annotated transcripts and ESTs (Affymetrix). Arrays were
washed at 25°C with 6 × SSPE (0.9 M NaCl, 60
mMNaH2PO4, 6 mM EDTA + 0.01% Tween 20) followed
by a stringent wash at 50°C with 100 mM MES, 0.1 M
NaCl, 0.01% Tween 20. The arrays were then stained with
phycoerythrein-conjugated streptavidin (Molecular
Probes) and the fluorescence intensities were determined
using the GCS 3000 high-resolution confocal laser scan-
ner (Affymetrix). The scanned images were analyzed using
programs resident in GeneChip Operating System v1.2
(GCOS; Affymetrix). Sample loading and variations in
staining were standardized by scaling the average of the
fluorescent intensities of all genes on an array to a con-
stant target intensity of 250 for all arrays used. The expres-
sion data were analyzed as previously described by
Lockhart et al[50]. The signal intensity for each gene was
calculated as the average intensity difference, represented
by (PM - MM)/(number of probe pairs)], where PM and
MM denote perfect-match and mismatch probes.
Five separate RNA preparations were hybridized for each
microglial infection condition, including Control (mock
infected), Fr57E-, and FrCasE-infected microglia. Microar-
ray Suite 5.0 from Affymetrix was used to generate
Present/Absent calls and Cel intensity files. Cel file data
were analyzed using DNA-Analyzer software (dChip ver-
sion 1.4) [51,52]. The median intensity value of the Cel
file data of the 15 arrays varied from 78 to 170 and was
normalized at the probe cell level to make them compara-
ble across all 15 arrays using the invariant set normaliza-
tion (ISN) method. ISN chooses a subset of PM probes
with small within-subset rank difference between the
baseline array and array being normalized to serve as the
basis for fitting a normalization curve. Array 15 was used
as the baseline array with a median intensity value of 125.
Gene expression values were then calculated with a
model-based expression indexes (MBEI) approach. MBEI
is the weighted average of PM/MM differences or back-
ground-adjusted PM values of selected probes. The calcu-
lated expression levels were saved with standard errors as
measurement accuracy, which were subsequently used to
compute 95% confidence intervals of fold changes for
two-group comparisons. The lower confidence bounds ofRetrovirology 2006, 3:26 http://www.retrovirology.com/content/3/1/26
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fold changes were conservative estimates of the real fold
changes. In addition, genes with increased or decreased
expression of more than 2-fold (lower confidence bound)
were chosen in order to focus on gene expression changes
that could have a significant impact on cell physiology. In
addition, probe sets for all genes showing increased
expression levels greater than 8-fold in infected cells (and
with uninfected cells showing normalized fluorescence
intensity values less than 50) were screened for potential
cross hybridization to viral RNA by performing probe
level sequence alignment with FrCasE and Fr57E RNA
genomes. Probe alignments with 100% nucleotide iden-
tity were considered to have the potential for cross hybrid-
ization and thus to be indicative of virus-specific signals
rather than cellular gene expression changes.
The complete data sets for the microarray analyses per-
formed herein, including the normalized data and exper-
imental details, are available at the European
Bioinformatics Institute, Microarray Informatics MIAMEx-
press website, accession number E-MEXP-459 [38]. In
addition, a copy of the normalized data set is provided as
an additional file (see Additional file 1).
Immunofluorescence and Western immunoblotting
Immunochemical staining for Env expression in microglia
was carried out as previously described [32] using mono-
clonal antibody 697 for FrCasE, and a goat anti-Friend
MLV Env for Fr57E (a generous gift from R. Friedrich, Jus-
tus Liebig University, Germany). Western Blotting of
microglial samples for Env and Gag expression were car-
ried out as described previously [32]. Env proteins from
FrCasE and Fr57E infected cells were detected using goat
anti-Friend MLV Env polyclonal antiserum diluted
1:2000. In addition, FrCasE Env was detected with mono-
clonal antibody 697. Gag proteins were detected using
antiserum R3 raised to denatured CasBrE p30gag at a dilu-
tion of 1:2000. Western blotting for SIGIRR was carried
out on microglial extracts as previously described [32]
using either a goat polyclonal antibody or a rat mono-
clonal antibody directed to the SIGIRR extracellular
domain (1:50–100; R&D Systems). Immunoblotting for
CHOP (GADD 153) protein expression was performed on
cellular extracts taken from microglia and mixed glial cul-
tures (1°CNS) after treatment for 24 hours with either 1
µM Thapsigargin or vehicle control (DMSO), using Rab-
bit-anti-CHOP polyclonal antibody (F-168; Santa Cruz)
at 1 µg/ml. Primary antibodies were detected using species
specific secondary antibodies coupled to horseradish-per-
oxidase. All blots were developed with chemilumines-
cence substrate (Pierce) and signals were detected by
exposure to x-ray film. Total protein equivalents were
loaded in each lane and confirmed by coomassie blue R-
250 staining of equivalent gels run in parallel.
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